Japan’s M&A deal of the year
Takeda Pharma’s acquisition of drugs-maker Millennium last May cemented it as a global force in pharmaceuticals. The deal offered a number of synergies and represented the pinnacle of a Japanese market trend.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts